<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02429856</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00002407</org_study_id>
    <nct_id>NCT02429856</nct_id>
  </id_info>
  <brief_title>Posterior Cruciate Retaining (PCR) Versus Posterior Cruciate Substituting (PCS) Total Knee Arthroplasty (TKA)</brief_title>
  <acronym>SCORPIO™</acronym>
  <official_title>SCORPIO™ Posterior Stabilized Versus Posterior Retained Total Knee Arthroplasties: Long-term Functional and Radiographic Outcome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alberta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alberta</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized clinical trial (RCT) examined 10 year outcomes comparing SCORPIO™ Posterior
      Cruciate Substituting (PCS) versus Posterior Cruciate Retaining (PCR) Total Knee Arthroplasty
      (TKA) as the primary outcome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      RCT of 100 subjects undergoing primary TKA who were randomized to received either a SCORPIO™
      PCS or PCR TKA.

      Subjects were evaluated pre-operatively and at 2 and 10 years post-operatively using the
      Western Ontario (WOMAC) Osteoarthritis Index, the RAND-36 and knee range of motion (2 years
      only). Complication and revision rates were also evaluated.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 1999</start_date>
  <completion_date type="Actual">May 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Western Ontario McMaster (WOMAC) Osteoarthritis Index Pain</measure>
    <time_frame>10 years postoperative</time_frame>
    <description>disease-specific patient reported health related quality of life (pain and function) with 2 constructs (pain; function) each ranging from 0-100 points No total score is calculated; we report the WOMAC in reverse order to align with the RAND-36 scores where higher scores are considered better than lower scores</description>
  </primary_outcome>
  <primary_outcome>
    <measure>WOMAC Osteoarthritis Index Function</measure>
    <time_frame>10 years</time_frame>
    <description>disease-specific patient reported health related quality of life (pain and function) with 2 constructs (pain; function) each ranging from 0-100 points No total score is calculated; we report the WOMAC in reverse order to align with the RAND-36 scores where higher scores are considered better than lower scores</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>RAND -36 Health Survey</measure>
    <time_frame>10 years postoperative</time_frame>
    <description>generic patient reported health related quality of life measure with 8 dimensions of health - we report the physical function dimension only with scores ranging from 0-100 where higher scores indicate better physical function.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Revision Rate</measure>
    <time_frame>within 10 years of surgery</time_frame>
    <description>number of participants with revision surgery (ie another surgery on the same knee) for any cause data obtained from patient report and regional administrative databases</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Complications</measure>
    <time_frame>within 10 years of surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee Range of Motion</measure>
    <time_frame>knee ROM at 2 years postoperative</time_frame>
    <description>Knee Range of Motion measured as a calculated total of knee flexion + knee extension; measured in degrees</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Arthroplasty, Replacement, Knee</condition>
  <condition>Knee Arthroplasty, Total</condition>
  <arm_group>
    <arm_group_label>PCS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>SCORPIO™ Posterior Cruciate Ligament Substituting TKA prosthesis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PCR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>SCORPIO™ Posterior Cruciate Ligament Retaining TKA prosthesis</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SCORPIO™</intervention_name>
    <description>subjects randomized at surgery to receive 1 of the 2 specified implants</description>
    <arm_group_label>PCR</arm_group_label>
    <arm_group_label>PCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  scheduled for primary TKA

          -  non-inflammatory arthritis

          -  intact Posterior Cruciate Ligament at the time of surgery

        Exclusion Criteria:

          -  required bone grafting of either the femur or tibia

          -  varus or valgus deformity of &gt; 15 degrees

          -  previous high tibial osteotomy

          -  unable to understand or comply with the study requirements

          -  unable to provide signed informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Alberta Health Services - Edmonton zone</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>TG6 2B7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <results_reference>
    <citation>Chaudhary R, Beaupré LA, Johnston DW. Knee range of motion during the first two years after use of posterior cruciate-stabilizing or posterior cruciate-retaining total knee prostheses. A randomized clinical trial. J Bone Joint Surg Am. 2008 Dec;90(12):2579-86. doi: 10.2106/JBJS.G.00995.</citation>
    <PMID>19047702</PMID>
  </results_reference>
  <verification_date>December 2016</verification_date>
  <study_first_submitted>April 17, 2015</study_first_submitted>
  <study_first_submitted_qc>April 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2015</study_first_posted>
  <results_first_submitted>December 12, 2016</results_first_submitted>
  <results_first_submitted_qc>May 10, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">May 13, 2019</results_first_posted>
  <last_update_submitted>May 10, 2019</last_update_submitted>
  <last_update_submitted_qc>May 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>PCS Group</title>
          <description>SCORPIO™ Posterior Cruciate Ligament Substituting TKA prosthesis
SCORPIO™: subjects randomized at surgery to receive 1 of the 2 specified TKA implants</description>
        </group>
        <group group_id="P2">
          <title>PCR Group</title>
          <description>SCORPIO™ Posterior Cruciate Ligament Retaining TKA prosthesis
SCORPIO™: subjects randomized at surgery to receive 1 of the 2 specified implants</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="49"/>
                <participants group_id="P2" count="51"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="32"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>PCS Group</title>
          <description>SCORPIO™ Posterior Cruciate Ligament Substituting TKA prosthesis
SCORPIO™: subjects randomized at surgery to receive 1 of the 2 specified implants</description>
        </group>
        <group group_id="B2">
          <title>PCR Group</title>
          <description>SCORPIO™ Posterior Cruciate Ligament Retaining TKA prosthesis
SCORPIO™: subjects randomized at surgery to receive 1 of the 2 specified implants</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="49"/>
            <count group_id="B2" value="51"/>
            <count group_id="B3" value="100"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="70.2" spread="8.4"/>
                    <measurement group_id="B2" value="69.2" spread="9.1"/>
                    <measurement group_id="B3" value="69.7" spread="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Western Ontario McMaster (WOMAC) Osteoarthritis Index Pain</title>
        <description>disease-specific patient reported health related quality of life (pain and function) with 2 constructs (pain; function) each ranging from 0-100 points No total score is calculated; we report the WOMAC in reverse order to align with the RAND-36 scores where higher scores are considered better than lower scores</description>
        <time_frame>10 years postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PCS Group</title>
            <description>SCORPIO™ Posterior Cruciate Ligament Substituting TKA prosthesis
SCORPIO™: subjects randomized at surgery to receive 1 of the 2 specified TKA implants</description>
          </group>
          <group group_id="O2">
            <title>PCR Group</title>
            <description>SCORPIO™ Posterior Cruciate Ligament Retaining TKA prosthesis
SCORPIO™: subjects randomized at surgery to receive 1 of the 2 specified TKA implants</description>
          </group>
        </group_list>
        <measure>
          <title>Western Ontario McMaster (WOMAC) Osteoarthritis Index Pain</title>
          <description>disease-specific patient reported health related quality of life (pain and function) with 2 constructs (pain; function) each ranging from 0-100 points No total score is calculated; we report the WOMAC in reverse order to align with the RAND-36 scores where higher scores are considered better than lower scores</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.0" spread="19.8"/>
                    <measurement group_id="O2" value="78.3" spread="24.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>WOMAC Osteoarthritis Index Function</title>
        <description>disease-specific patient reported health related quality of life (pain and function) with 2 constructs (pain; function) each ranging from 0-100 points No total score is calculated; we report the WOMAC in reverse order to align with the RAND-36 scores where higher scores are considered better than lower scores</description>
        <time_frame>10 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PCS Group</title>
            <description>SCORPIO™ Posterior Cruciate Ligament Substituting TKA prosthesis
SCORPIO™: subjects randomized at surgery to receive 1 of the 2 specified implants</description>
          </group>
          <group group_id="O2">
            <title>PCR Group</title>
            <description>SCORPIO™ Posterior Cruciate Ligament Retaining TKA prosthesis
SCORPIO™: subjects randomized at surgery to receive 1 of the 2 specified implants</description>
          </group>
        </group_list>
        <measure>
          <title>WOMAC Osteoarthritis Index Function</title>
          <description>disease-specific patient reported health related quality of life (pain and function) with 2 constructs (pain; function) each ranging from 0-100 points No total score is calculated; we report the WOMAC in reverse order to align with the RAND-36 scores where higher scores are considered better than lower scores</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.9" spread="25.6"/>
                    <measurement group_id="O2" value="72.7" spread="23.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>RAND -36 Health Survey</title>
        <description>generic patient reported health related quality of life measure with 8 dimensions of health - we report the physical function dimension only with scores ranging from 0-100 where higher scores indicate better physical function.</description>
        <time_frame>10 years postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PCS Group</title>
            <description>SCORPIO™ Posterior Cruciate Ligament Substituting TKA prosthesis
SCORPIO™: subjects randomized at surgery to receive 1 of the 2 specified TKA implants</description>
          </group>
          <group group_id="O2">
            <title>PCR Group</title>
            <description>SCORPIO™ Posterior Cruciate Ligament Retaining TKA prosthesis
SCORPIO™: subjects randomized at surgery to receive 1 of the 2 specified TKA implants</description>
          </group>
        </group_list>
        <measure>
          <title>RAND -36 Health Survey</title>
          <description>generic patient reported health related quality of life measure with 8 dimensions of health - we report the physical function dimension only with scores ranging from 0-100 where higher scores indicate better physical function.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.4" spread="28.7"/>
                    <measurement group_id="O2" value="50.3" spread="29.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Revision Rate</title>
        <description>number of participants with revision surgery (ie another surgery on the same knee) for any cause data obtained from patient report and regional administrative databases</description>
        <time_frame>within 10 years of surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PCS Group</title>
            <description>SCORPIO™ Posterior Cruciate Ligament Substituting TKA prosthesis
SCORPIO™: subjects randomized at surgery to receive 1 of the 2 specified TKA implants</description>
          </group>
          <group group_id="O2">
            <title>PCR Group</title>
            <description>SCORPIO™ Posterior Cruciate Ligament Retaining TKA prosthesis
SCORPIO™: subjects randomized at surgery to receive 1 of the 2 specified TKA implants</description>
          </group>
        </group_list>
        <measure>
          <title>Revision Rate</title>
          <description>number of participants with revision surgery (ie another surgery on the same knee) for any cause data obtained from patient report and regional administrative databases</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Complications</title>
        <time_frame>within 10 years of surgery</time_frame>
        <population>These complications include the revisions already recorded.</population>
        <group_list>
          <group group_id="O1">
            <title>PCS Group</title>
            <description>SCORPIO™ Posterior Cruciate Ligament Substituting TKA prosthesis
SCORPIO™: subjects randomized at surgery to receive 1 of the 2 specified TKA implants</description>
          </group>
          <group group_id="O2">
            <title>PCR Group</title>
            <description>SCORPIO™ Posterior Cruciate Ligament Retaining TKA prosthesis
SCORPIO™: subjects randomized at surgery to receive 1 of the 2 specified TKA implants</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Complications</title>
          <population>These complications include the revisions already recorded.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Knee Range of Motion</title>
        <description>Knee Range of Motion measured as a calculated total of knee flexion + knee extension; measured in degrees</description>
        <time_frame>knee ROM at 2 years postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PCS Group</title>
            <description>SCORPIO™ Posterior Cruciate Ligament Substituting TKA prosthesis
SCORPIO™: subjects randomized at surgery to receive 1 of the 2 specified TKA implants</description>
          </group>
          <group group_id="O2">
            <title>PCR Group</title>
            <description>SCORPIO™ Posterior Cruciate Ligament Retaining TKA prosthesis
SCORPIO™: subjects randomized at surgery to receive 1 of the 2 specified TKA implants</description>
          </group>
        </group_list>
        <measure>
          <title>Knee Range of Motion</title>
          <description>Knee Range of Motion measured as a calculated total of knee flexion + knee extension; measured in degrees</description>
          <units>degrees</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="105.8" spread="13.5"/>
                    <measurement group_id="O2" value="105.9" spread="13.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>PCS Group</title>
          <description>SCORPIO™ Posterior Cruciate Ligament Substituting TKA prosthesis
SCORPIO™: subjects randomized at surgery to receive 1 of the 2 specified TKA implants</description>
        </group>
        <group group_id="E2">
          <title>PCR Group</title>
          <description>SCORPIO™ Posterior Cruciate Ligament Retaining TKA prosthesis
SCORPIO™: subjects randomized at surgery to receive 1 of the 2 specified TKA implants</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="49"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Revision of TKA</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="49"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Director of NACTRC</name_or_title>
      <organization>UAlberta</organization>
      <phone>780-407-8007</phone>
      <email>ron.welch@ahs.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

